Author

Michael Wax

University of California, San Francisco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Alexey V. BazaroviD· 2 shared Jasleen Kukreja· 2 shared Paul J. WoltersiD· 2 shared Ram Prasad NaikawadiiD· 2 shared Andrea Serra-MarquesiD· 1 shared Ayushi AgrawaliD· 1 shared David Garfield· 1 shared Gary A. Green· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Alexey V. BazarovORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NINTEDANIB AND PIRFENIDONE AFFECT GROWTH AND DIFFERENTIATION OF HUMAN ALVEOLAR TYPE 2 CELLS

Alexey V. Bazarov, Andrea Serra-Marques, Giulia Protti, Monica M. Yang, Ram Prasad Naikawadi, Gary A. Green, Seoyeon Lee, Jasleen Kukreja, Michael A. Matthay, Michael Wax, Xiaodan Cai, Rachel M. Wolters, Jason R. Rock, David Garfield, Paul J. Wolters

This study investigates how pirfenidone and nintedanib affect the growth and differentiation of human alveolar type 2 cells in organoid cultures, revealing differences in their impact on surfactant protein C expression and cell identity.

bioRxiv · Mar 3, 2026 · PreprintCell Biology

Cellular profiling identifies an early profibrotic alveolar type 2 cell signature in lung fibrosis

Ram Prasad Naikawadi, Alexey V. Bazarov, Michael Wax, Kaveh Boostanpour, Jasleen Kukreja, Michela Traglia, Ayushi Agrawal, Reuben Thomas, Mallar Bhattacharya, Paul J. Wolters

The paper identifies an early profibrotic alveolar type 2 cell signature in lung fibrosis using single-cell RNA sequencing and shows that p53 inhibition can reverse fibrosis.

American Journal of Respiratory and Critical Care Medicine · Feb 4, 2026Peer-reviewedCell Biology